S4V2 will be tested for safety and preliminary efficacy in approximately 120 healthy Shigella -naïve participants aged 18 to 50 years at three sites in the United States. The study, sponsored and ...
KEMRI said in a statement issued in Nairobi, the capital of Kenya, that the Phase I clinical trial of TNX-801, an investigational vaccine designed to prevent mpox will take place in Kenya, focusing on ...
Vaccines that prevent smallpox and mpox come in two varieties. One uses a single shot of a live virus but carries the risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback